Skip to product information
1 of 1

BodyPharm

BP Femara 2

BP Femara 2

Regular price R 270.00 ZAR
Regular price Sale price R 270.00 ZAR
Sale Sold out
Shipping calculated at checkout.

Each pouch contains 30x 2mg film coated tablets.


Letrozole is a non-steroidal selective third generation aromatase inhibitor, which is being sold under the brand name Femara by the international drug-manufacturing firm Novartis. It is used to treat postmenopausal women with estrogen receptor-positive or estrogen receptor-unknown (unsure if the cancer is responsive to estrogen) breast cancer.The structure and activity of this compound are very similar to that of Arimidex (anastrozole), which is approved in the United States for the same purpose. Femara is typically used as a second line of treatment, after an estrogen-receptor antagonist like tamoxifen has failed to elicit a desirable response (although at times it is used as a first line option as well).

View full details